Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CYTARABINE vs DABRAFENIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CYTARABINE vs DABRAFENIB: Safety Overview

Metric CYTARABINE DABRAFENIB
Total FAERS Reports 44,383 19,305
Deaths Reported 9,089 4,165
Death Rate 20.5% 21.6%
Hospitalizations 17,861 5,325
Average Patient Age 38.0 yrs 58.3 yrs
% Female Patients 41.2% 48.0%
FDA Approval Date Approved Prior to Jan 1, 1982 Mar 16, 2023
Manufacturer Sagent Pharmaceuticals Novartis Pharmaceuticals Corporation
Route INTRATHECAL ORAL
Marketing Status Discontinued Prescription